Mounjaro Weight Loss Injection

We only supply Mounjaro in a multi-dose pen, which contains four identical doses. Always follow your doctor’s instructions and read the enclosed patient information leaflet carefully.

How to Inject:

• Injection Sites: Inject into the fat layer of your stomach or upper thighs, ensuring you avoid veins and muscles. You can also use your upper arms if there is enough fat, though it is best to have someone assist you.

• Needle Safety: Use a fresh needle for every injection and discard it immediately into a sharps bin. Do not use the pen or needle if they appear damaged, bent, or unsealed.

• Inspection: Check the liquid before injecting. It should be clear and either colourless or slightly yellowish; do not use it if it looks different.

• Verification: Double-check that you are administering the correct medication and strength according to your dosing schedule. This step is crucial if you use other injectables, such as insulin.

Mounjaro is not suitable for everyone. It requires a full clinical assessment before use, as certain medical conditions, medications, or risk factors can make treatment unsafe. Always provide your clinician with an accurate medical history during your consultation.

Critical Safety Warning: Thyroid Risks

Animal studies indicate that Mounjaro may increase the risk of thyroid tumors, including thyroid cancer. While not yet confirmed in humans, this is a serious safety warning.

Contact your healthcare provider immediately if you experience:

• A lump or swelling in your neck

• A persistent hoarse voice

• Difficulty swallowing

• Shortness of breath

Strict Contraindications (Do NOT Use Mounjaro)

Do not use this medication if you meet any of the following criteria:

• Personal or Family History: You or a family member have ever had Medullary Thyroid Carcinoma (MTC).

• Genetic Conditions: You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

• Allergies: You are allergic to tirzepatide or any other ingredient in the injection.

• Age: You are under 18 years old.

• Pregnancy & Breastfeeding: You are pregnant, planning to become pregnant, or currently breastfeeding.

• Diabetes Status: You have been diagnosed with type 1 diabetes.

• Severe Digestion Issues: You suffer from severe stomach conditions, including gastroparesis (delayed stomach emptying).

Conditions Requiring Extra Caution and Monitoring

Speak with a healthcare professional before starting Mounjaro if you have a history of:

• Pancreatitis

• Gallbladder problems (such as gallstones)

• Significant kidney disease or a high risk of dehydration (especially if prone to vomiting)

• Liver problems

• Diabetic retinopathy (diabetic eye disease), as rapid changes in blood sugar can impact this condition

• Severe allergic reactions to other injectable medicines

Medication Interaction Note: If you take other diabetes medications—particularly insulin or sulfonylureas—using Mounjaro may increase your risk of dangerously low blood sugar.

Ongoing Monitoring

Your safety requires continuous monitoring while on this weight loss treatment. Seek prompt medical advice if you experience severe stomach pain, persistent vomiting, signs of dehydration, or any other worrying symptoms. Always consult a healthcare professional to ensure Mounjaro is appropriate for your specific health needs.

Mounjaro contains tirzepatide as its active ingredient. Tirzepatide is a dual-action GLP-1 and GIP receptor agonist that helps regulate blood sugar levels and appetite, supporting effective weight loss and type 2 diabetes management.

In addition to the active ingredient, Mounjaro includes the following inactive ingredients to help stabilise the solution and maintain safety and effectiveness:

• Metacresol
• Sodium chloride
• Sodium phosphate
• Hydrochloric acid and/or sodium hydroxide (to adjust pH)
• Water for injections